FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
Representative Genomically-Driven Clinical Trials of Various FGFR... | Download Table
Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment - Liu - 2021 - Cell Proliferation - Wiley Online Library
Targeting FGFR inhibition in cholangiocarcinoma - Cancer Treatment Reviews
FGFR Inhibitors Make Inroads in Cholangiocarcinoma
Targeting FGF-FGFR - FGFRi in UC and Beyond - Module - FGFR Signaling in Cancer - Oncology - Clinical Care Options
List of clinical trials that assessed FGFR FISH as a biomarker when... | Download Table
Ongoing clinical trials testing FGFR inhibitors in patients affected by UC. | Download Scientific Diagram
Summary of ongoing clinical trials with FGFR inhibitors as monotherapy... | Download Scientific Diagram
FGFR Inhibition | FGFR Inhibitor Review
FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1–4 inhibitor in patients with advanced solid tumors - Annals of Oncology
Growth Factor Receptor Inhibitor - an overview | ScienceDirect Topics
Clinical trials with selective FGFR inhibitors. | Download Scientific Diagram
Ongoing clinical trials testing FGFR inhibitors in patients affected by UC. | Download Scientific Diagram
Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance | British Journal of Cancer
Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors | Communications Chemistry
Pan-FGFR inhibitors in different phases of clinical trials. | Download Scientific Diagram
FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application | Oncotarget
Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance | British Journal of Cancer
FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience | JCO Precision Oncology